William Harris Investors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

William Harris Investors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5.43M	Buy	+149,704	New	+$5.98M	1.56%	29

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

William Harris Investors's TEVA Position: Q4 2016 in Review

William Harris Investors opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q4 2016: 149,704 shares worth $5.43M. The stake represents 1.56% of the portfolio and ranks #29 among its holdings.

739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

William Harris Investors held 149,704 shares of Teva Pharmaceutical Industries Limited worth $5.43M as of Q4 2016.
Teva Pharmaceutical Industries Limited was a new William Harris Investors position in Q4 2016.
Teva Pharmaceutical Industries Limited made up 1.56% of William Harris Investors's portfolio in Q4 2016, its #29 holding.
739 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2016.

Based on William Harris Investors's 13F filing for Q4 2016, filed 7 Feb 2017.